KK
KLP Kapitalforvaltning Portfolio holdings
AUM $23.2B
This Quarter Return
+14.13%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$23.2B
AUM Growth
+$2.77B
(+14%)
Cap. Flow
+$677M
Cap. Flow
% of AUM
2.92%
Top 10 Holdings %
Top 10 Hldgs %
31.18%
Holding
2,276
New
24
Increased
1,240
Reduced
353
Closed
88
Top Buys
| 1 |
Microsoft
MSFT
|
+$44.7M |
| 2 |
Capital One
COF
|
+$44.4M |
| 3 |
Amazon
AMZN
|
+$35M |
| 4 |
NVIDIA
NVDA
|
+$32.4M |
| 5 |
Meta Platforms (Facebook)
META
|
+$20.1M |
Top Sells
| 1 |
HES
Hess
HES
|
+$54.3M |
| 2 |
DFS
Discover Financial Services
DFS
|
+$28.4M |
| 3 |
CMS Energy
CMS
|
+$12.9M |
| 4 |
NetApp
NTAP
|
+$12.7M |
| 5 |
Hologic
HOLX
|
+$12.7M |
Sector Composition
| 1 | Technology | 33.47% |
| 2 | Financials | 14% |
| 3 | Consumer Discretionary | 10.47% |
| 4 | Healthcare | 10.11% |
| 5 | Communication Services | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TGI
1501
DELISTED
Triumph Group
TGI
| $368K | ﹤0.01% |
14,300
-2,300
| -14% | -$59.2K |
|
1502
UFP Technologies
UFPT
$1.6B
| $366K | ﹤0.01% |
1,500
| – | – |
|
1503
LeMaitre Vascular
LMAT
$2.1B
| $365K | ﹤0.01% |
4,400
+600
| +16% | +$49.8K |
|
1504
Denali Therapeutics
DNLI
$1.97B
| $365K | ﹤0.01% |
26,100
| – | – |
|
1505
Select Medical
SEM
$1.53B
| $364K | ﹤0.01% |
24,000
+3,300
| +16% | +$50.1K |
|
1506
IDEAYA Biosciences
IDYA
$2.18B
| $364K | ﹤0.01% |
17,300
+2,400
| +16% | +$50.4K |
|
1507
Mercury Insurance
MCY
$4.32B
| $364K | ﹤0.01% |
5,400
-700
| -11% | -$47.1K |
|
1508
Newmark Group
NMRK
$3.41B
| $362K | ﹤0.01% |
29,805
| – | – |
|
1509
ArcBest
ARCB
$1.65B
| $362K | ﹤0.01% |
4,700
| – | – |
|
1510
Gray Television
GTN
$574M
| $361K | ﹤0.01% |
79,600
| – | – |
|
1511
Standex International
SXI
$2.55B
| $360K | ﹤0.01% |
2,300
-200
| -8% | -$31.3K |
|
1512
DigitalOcean
DOCN
$3.36B
| $360K | ﹤0.01% |
12,600
| – | – |
|
|
HTO
1513
H2O America Common Stock
HTO
$1.72B
| $359K | ﹤0.01% |
6,900
+800
| +13% | +$41.6K |
|
1514
BioCryst Pharmaceuticals
BCRX
$1.63B
| $357K | ﹤0.01% |
39,800
| – | – |
|
1515
Sunrun
RUN
$3.76B
| $356K | ﹤0.01% |
43,500
| – | – |
|
1516
Enovis
ENOV
$1.89B
| $355K | ﹤0.01% |
11,333
| – | – |
|
1517
Constellium
CSTM
$2.11B
| $354K | ﹤0.01% |
+26,600
| New | +$354K |
|
1518
Phreesia
PHR
$1.42B
| $353K | ﹤0.01% |
12,400
+2,100
| +20% | +$59.8K |
|
1519
Par Pacific Holdings
PARR
$1.8B
| $353K | ﹤0.01% |
13,300
-13,100
| -50% | -$348K |
|
1520
AvidXchange
AVDX
$2.07B
| $352K | ﹤0.01% |
36,000
| – | – |
|
1521
Surgery Partners
SGRY
$2.78B
| $351K | ﹤0.01% |
15,800
+2,900
| +22% | +$64.5K |
|
1522
GeneDx Holdings
WGS
$3.62B
| $351K | ﹤0.01% |
3,800
-500
| -12% | -$46.2K |
|
1523
Genesco
GCO
$376M
| $350K | ﹤0.01% |
17,800
| – | – |
|
1524
Federal Agricultural Mortgage
AGM
$2.06B
| $350K | ﹤0.01% |
1,800
-200
| -10% | -$38.9K |
|
1525
Unitil
UTL
$817M
| $349K | ﹤0.01% |
6,700
+800
| +14% | +$41.7K |
|